References
- 1. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of SLE. Am J Med 1976; 60: 221–5.
- 2. Manzi S, Meilahn E.N, Raairie J.E. et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiology 1997; 145(5): 408–415.
- 3. Gladman DD,Urowitz MB:Mortality in systemic lupus erythematosus. J Rheumatool Suppl 1987, 14(Suppl 13): 223–225.
- 4. Petri M, Perez_Gutthann S, Spence D, Hochberg MC:Risk factor for coronary artery disease in patients with systemic lupus erythemtosus. Am J Med 1992, 93: 513–519.10.1016/0002-9343(92)90578-Y
- 5. Esdaile ЈM, Abrahamowitz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis and Rheumatism 2001; 44(10): 2331–2337.
- 6. Doria A, Iaccarino L, Ghirardello A, Zampieri S, Aarienti S, Sarzi-Puttini P, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006; 119: 700–6.
- 7. Teixeira V and Tam Lai-Shan.N ovel Insights in Systemic Lupus Erythematosus and Atherosclerosis. January 2018 | Volume 4 | Article 262, Frontiers in Medicine | www.frontiersin.org.
- 8. Fadda S, Nassar H, Gamal SM, Al-azizi H: Sub-clinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indices.Z Rheumatol. 2015 Aug; 74(6): 529–32. doi: 10.1007/s00393-014-1473-1.
- 9. Manzi S, Selzer F, Sutton –Tyrelli K et al. Prevalence and risk factors of carotid plaque in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 51–60.
- 10. Nermeen Khairy, Yasser Ezzat, Nahla Naeem, Radwa Taha, Rasha Wesam.Atherosclerosis bio-markers in female systemic lupus erythematosus patients with and without cardiovascular diseases. The Egyptian Rheumatologist (2017) 39, 7–12.
- 11. Sharma SK, Rathi M, Sahoo S, Prakash M, Dhir V, Singh S. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis. Lupus (2016) 25(5): 525–31. doi:10.1177/0961203315622822.10.1177/0961203315622822
- 12. Meroni P, Raschi E, Testoni C, Borghi M. Endothelial cell activation by antiphospholipid antibodies. Clin Immunol (2004) 112(2): 169–74. doi:10.1016/j.clim.2004.02.015.10.1016/j.clim.2004.02.015
- 13. Sallai KK, Nagy E, Bodó I, Mohl A, Gergely P. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors. Scand J Rheumatol (2007) 36(3): 198–205. doi:10.1080/03009740601089283.10.1080/03009740601089283
- 14. Roman MJ, Shanker B, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349(2): 399–406.
- 15. Plazak W, Gryga K, Dziedzic H, Tomkiewicz-Pajak L, Konieczynska M, Podolec P, Musial J. Influence of atorvastatin on coronary calcifications and Myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, doubled-masked, placebo-controlled study. Arthritis Research & Therapy 2011,13: R117.10.1186/ar3402
- 16. Boucelma M, Tahmi M, Chaudet H, Drahmoune R,Bouyoucef SE,Berrah A.Assessment of myocardial perfusion in systemic lupus erythematosus. La Revue de Médecine Interne 30(2):119-24 • October 2008 DOI: 10.1016/j.revmed.2008.06.022.10.1016/j.revmed.2008.06.022
- 17. Zakavi SR, Joukar MH, Dabagh Kakhi VR, Khazael Gh, Ariana K. Prognostic evaluation of myocardial perfusion scintigraphy in patients with systemic lupus erythematosus admitted in the hospital for noncardiac problems. Iranian Journal of Nuclear medicine 2006; 14(suppl): 14–15.
- 18. Sella E.M, Saato E.I. and Barbieri A.. Coronary Artery Angiography in Systemic Lupus Erythematosus Patients With Abnormal Myocardial Perfusion Scintigraphy. Arthritis & Rheumatism 2003; 48 (11): 3168–3175.
- 19. Czzuszynska Z, Romanowwicz G. Myocardial perfusion in women with systemic lupus erythematosus and no symptoms of coronary artery disease. Nucl Med Rev Cbet East Eur 2004; 7(2): 171–174.
- 20. Sun S.-S, Shiau Y.-C, Tsai S.-C, Lin C.-C, Kao A, and Lee C.-C. The role off 99mTc-sestamibi myocardial perfusion single-photon emission computed tomography (SPECT) in the detection of cardiovascular involvement in systemic lupus erythematosus with nonspecific chest complaints. Rheumatology 2011; 400: 1106–1111.
- 21. Nikpour M, Gladman D, Ibafiez D, Bruce IN, Burns R, Urowitz. Myocardial perfusion imaging in assessing risk of coronary events in patients with systemic lupus erythematosus. J Rheumatol, 2009; 36(2)(2): 288–294.10.3899/jrheum.080776
- 22. Baharfard N, Shiroodi MK, Fotoohi F,Samangooie Sh,Asli N,Eghyesadi0Araghi P, Javadi H,Semnani Sh,Amini A,Assadi M:Myocardial perfusion imaging using a technetium-99m Sestamibi in asymptomatic and low risk for coronary artery disease patients with diagnosed systemic lupus erythematosus. Perfusion 2010, 26(2), 151–157.
- 23. Delcour KS, Khaja A, Chockalingam A, Kuppuswamy S, Dresser T.Outcomes in patients with abnormal myocardial perfusion imaging and normal coronary angiograms. Angiology 2009 Jun-Jul; 60(3): 318–321.10.1177/0003319708319938
- 24. Alqaisi F,Albadrin F,Jaffery Z,et al.Prognostic predictors and outcomes in patients with abnormal myocardial perfusion imaging and angiographically insignificant coronary artery disease. J Nucl Cardiol 2008 Nov-Dec; 15(6): 758–761.
- 25. Othman KMS and Assaf NY. Early detection of premature subclinical coronary atherosclerosis I systemic lupus erythematosus. The Egyptian Heart Journal (2013) 65, 281–288.
- 26. Ishimori MI, Martin R, Berman DS et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. J Am Coll Cardiol Img 2011; 4: 27–33.